Royal London Asset Management LTD Horizon Therapeutics Public LTD CO Transaction History

Royal London Asset Management LTD

$39.3 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $272,689 - $318,863	2,755 Added 3.43%	83,038 $9.61 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $427,460 - $498,630	4,437 Added 5.85%	80,283 $8.26 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $50,225 - $53,118	-468 Reduced 0.61%	75,846 $8.28 Million
Q4 2022 Feb 09, 2023	BUY	$62.39 - $113.8 $344,642 - $628,631	5,524 Added 7.8%	76,314 $8.68 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $516,080 - $741,624	-8,759 Reduced 11.01%	70,790 $4.38 Million

Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $581,433 - $738,801	6,728 Added 9.24%	79,549 $8.37 Million
Q4 2021 Oct 18, 2022	BUY	$98.56 - $119.91 $118,567 - $144,251	1,203 Added 1.68%	72,821 $7.85 Million
Q4 2021 Aug 16, 2022	BUY	$98.56 - $119.91 $7.18 Million - $8.73 Million	72,821 New	72,821 $7.85 Million
Q4 2021 Jan 18, 2022	SELL	$98.56 - $119.91 $7.06 Million - $8.59 Million	-71,618 Closed	0 $0
Q3 2021 Oct 18, 2022	BUY	$91.91 - $110.37 $19,301 - $23,177	210 Added 0.29%	71,618 $7.84 Million
Q3 2021 Aug 16, 2022	BUY	$91.91 - $110.37 $6.58 Million - $7.9 Million	71,618 New	71,618 $7.84 Million
Q3 2021 Nov 02, 2021	SELL	$91.91 - $110.37 $6.56 Million - $7.88 Million	-71,408 Closed	0 $0
Q2 2021 Oct 18, 2022	SELL	$86.24 - $95.92 $702,079 - $780,884	-8,141 Reduced 10.23%	71,408 $6.69 Million
Q2 2021 Aug 16, 2022	BUY	$86.24 - $95.92 $6.16 Million - $6.85 Million	71,408 New	71,408 $6.69 Million
Q2 2021 Jul 14, 2021	SELL	$86.24 - $95.92 $6.11 Million - $6.8 Million	-70,858 Closed	0 $0
Q1 2021 Oct 17, 2022	SELL	$71.83 - $95.48 $624,274 - $829,816	-8,691 Reduced 10.93%	70,858 $6.52 Million
Q1 2021 Aug 16, 2022	BUY	$71.83 - $95.48 $5.09 Million - $6.77 Million	70,858 New	70,858 $6.52 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account